May 27, 2008

Medication Management & Lupus -- the Wed., May 28 Webchat at the Lupus Foundation of America

Morning all.

Wanted to give you a reminder about the Lupus Foundation of America's Webchat this Wednesday afternoon, May 28, at 3 p.m. Eastern Time.

Dr. Joan T. Merrill, the Medical Director of the Lupus Foundation of America, will serve as the guest expert for the Medication Management & Lupus chat.

Joan T. Merrill, M.D., is currently Head of the Clinical Pharmacology Research Program at Oklahoma Medical Research Foundation (OMRF), OMRF Professor of Medicine at the University of Oklahoma Health Sciences Center and Assistant Professor of Medicine at Columbia University in New York City. She received her medical training at Cornell University Medical College, New York, NY, followed by an internship and residency at St. Luke’s/Roosevelt Hospital Center, a fellowship in rheumatology at NYU Medical Center and a basic research fellowship in the Department of Pediatrics at Columbia University.

Dr. Merrill’s research focus is the study of genetics and pathophysiology relevant to atherosclerosis risk in lupus and antiphospholipid syndrome, for which she has received multiple foundation and NIH grants. She has numerous publications in journals such as the Journal of Immunology, the Journal of Clinical Rheumatology, and the New England Journal of Medicine. She is a sought-after speaker at clinical symposia both nationally and internationally.

Dr. Merrill is a member of the Lupus Foundation of America’s Medical Scientific Advisory Council. She is the co-chair of the American College of Rheumatology’s Study Group and member of the Food and Drug Administration’s Arthritis Drugs Advisory Committee, in addition to many other active professional appointments.

We certainly hope you can join us Wednesday afternoon. To do so, you can log in to the live chat here.

After the chat, you are invited to continue the discussion in our message boards.

As always, copies of all chat transcripts are posted online within a day or 2 of the chat. Visit here to read the LFA's previous chat transcripts.

No comments: